Sofinnova Investments’s NextCure NXTC Stock Holding History

Sofinnova Investments’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Hold	222,654	–	–	0.02%	55
2026 Q1	$2.38M	Hold	222,654	–	–	0.09%	62
2025 Q4	$3.16M	Hold	222,654	–	–	0.14%	47
2025 Q3	$1.3M	Sell	222,654 -1	-0%	-$5	0.07%	54
2025 Q2	$1.23M	Hold	222,655	–	–	0.08%	53
2025 Q1	$1.28M	Hold	222,655	–	–	0.08%	56
2024 Q4	$2.06M	Hold	222,655	–	–	0.15%	48
2024 Q3	$3.66M	Hold	222,655	–	–	0.29%	47
2024 Q2	$4.25M	Hold	222,655	–	–	0.22%	57
2024 Q1	$5.96M	Hold	222,655	–	–	0.33%	48
2023 Q4	$3.05M	Hold	222,655	–	–	0.17%	43
2023 Q3	$3.45M	Hold	222,655	–	–	0.22%	50
2023 Q2	$4.81M	Hold	222,655	–	–	0.32%	38
2023 Q1	$3.95M	Hold	222,655	–	–	0.25%	41
2022 Q4	$3.77M	Hold	222,655	–	–	0.22%	41
2022 Q3	$7.35M	Hold	222,655	–	–	0.43%	37
2022 Q2	$12.6M	Hold	222,655	–	–	1.05%	25
2022 Q1	$13M	Hold	222,655	–	–	0.99%	25
2021 Q4	$16M	Hold	222,655	–	–	0.94%	29
2021 Q3	$18M	Hold	222,655	–	–	1.07%	20
2021 Q2	$21.5M	Hold	222,655	–	–	1.24%	22
2021 Q1	$26.7M	Buy	+222,655	New	+$32.2M	1.61%	16
2020 Q4	–	Sell	-222,655	Closed	-$23.5M	–	76
2020 Q3	$23.5M	Hold	222,655	–	–	1.74%	14
2020 Q2	$57.3M	Hold	222,655	–	–	3.61%	6
2020 Q1	$99M	Hold	222,655	–	–	9.16%	3
2019 Q4	$151M	Buy	222,655 +12,500	+6%	+$6.27M	10.85%	2
2019 Q3	$77.8M	Hold	210,155	–	–	7.03%	4
2019 Q2	$37.8M	Buy	+210,155	New	+$43.7M	3.47%	9

Other funds holding NXTC

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Verdad Advisers Boston, Massachusetts $104M AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sofinnova Investments's NXTC Position: Q2 2026 in Review

Sofinnova Investments held its NextCure (NXTC) position steady in Q2 2026 at 222,654 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #55.

Sofinnova Investments first reported a position in NXTC in Q2 2019 and has held it in 28 quarters since. The position peaked at $151M in Q4 2019. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

Sofinnova Investments held 222,654 shares of NextCure worth $356K as of Q2 2026.
Sofinnova Investments left its NextCure share count unchanged in Q2 2026.
NextCure made up 0.02% of Sofinnova Investments's portfolio in Q2 2026, its #55 holding.
Sofinnova Investments first reported a position in NextCure in Q2 2019 and has held it in 28 quarters since.
Sofinnova Investments's NextCure position peaked at $151M in Q4 2019.
30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.